Impact of Advanced Cardiac Life Support Medications on Discharge Neurological Function for Survivors of Cardiac Arrest When Using ECPR
Our data support that increasing doses of epinephrine and nonantiarrhythmic advanced cardiovascular life support medications both worsen the probability of neurologically intact survival for patients who undergo extracorporeal cardiopulmonary resuscitation.
Authors
- Joshua John Horns (ORCID: https://orcid.org/0000-0002-0602-2900)
- Nicholas J. Johnson (ORCID: https://orcid.org/0000-0001-9915-0591)
- Maxwell A. Hockstein (ORCID: https://orcid.org/0000-0003-4314-973X)
- Joeseph Tonna
- Scott T. Youngquist
- Sung-Min Cho
Institutions
- Johns Hopkins University (US)
- Georgetown University (US)
- University of Washington (US)
- University of Utah (US)
- Johns Hopkins Medicine (US)
- MedStar Georgetown University Hospital (US)
- Utah Department of Health (US)
- University of Utah Health Care (US)
Publication Details
- Journal
- Circulation Heart Failure
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1161/circheartfailure.125.013420
- Citations
- 1
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 38.36